JP Stock MarketDetailed Quotes

5935 Gantan Beauty Industry

Watchlist

2066
+1+0.05%

20min DelayMarket Closed Dec 30 15:30 JST

7.97BMarket Cap20.39P/E (Static)

Gantan Beauty Industry Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

4.32%14.25B

20.89%3.44B

-7.64%4.22B

-6.14%3.65B

24.60%2.95B

21.73%13.66B

-9.93%2.84B

41.26%4.56B

48.56%3.89B

6.70%2.37B

Cost of revenue

4.99%9.85B

14.73%2.39B

-6.10%2.86B

-4.19%2.47B

27.11%2.13B

21.56%9.38B

-3.14%2.08B

44.34%3.05B

37.60%2.58B

5.77%1.68B

Gross profit

2.85%4.4B

37.75%1.05B

-10.73%1.36B

-9.96%1.18B

18.49%818.17M

22.10%4.28B

-24.43%761.04M

35.47%1.52B

76.19%1.31B

9.02%690.5M

Operating expense

12.00%3.83B

10.94%1.08B

10.64%995.52M

13.05%881.33M

13.88%875.24M

6.98%3.42B

16.28%974.49M

8.53%899.82M

-0.48%779.59M

2.64%768.57M

Operating profit

-33.76%566.73M

84.67%-32.73M

-41.81%359.73M

-43.88%296.8M

26.90%-57.07M

181.08%855.56M

-226.25%-213.45M

112.09%618.26M

1,398.19%528.82M

32.38%-78.07M

Net non-operating interest income (expenses)

4.96%-8.66M

-21.62%-2.7M

13.69%-2.5M

20.83%-1.88M

2.47%-1.58M

19.64%-9.11M

17.83%-2.22M

14.86%-2.9M

17.38%-2.37M

31.33%-1.62M

Non-operating interest expense

-4.96%8.66M

21.62%2.7M

-13.69%2.5M

-20.83%1.88M

-2.47%1.58M

-19.64%9.11M

-17.83%2.22M

-14.86%2.9M

-17.38%2.37M

-31.33%1.62M

Net investment income

4.76%13.2M

4.51%12.6M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

16.27%-6.13M

5.79%-1.73M

27.38%-1.33M

19.29%-1.48M

12.62%-1.6M

41.52%-7.32M

49.66%-1.83M

61.85%-1.83M

10.73%-1.83M

10.07%-1.83M

Less:Impairment of capital assets

-16.27%6.13M

-17.09%1.52M

-22.84%1.41M

-12.51%1.6M

-12.62%1.6M

-10.26%7.32M

-10.11%1.83M

-10.12%1.83M

-10.73%1.83M

-10.07%1.83M

Less:Other special charges

----

---83K

----

Other non-operating income (expenses)

-24.35%22.17M

57.36%7.32M

-47.99%3.91M

-1.55%3.75M

-46.04%7.2M

433.53%29.31M

203.96%4.65M

788.73%7.51M

25.05%3.81M

66.41%13.33M

Income before tax

-33.34%587.31M

85.98%-29.84M

-42.06%359.81M

-43.76%297.19M

28.31%-39.85M

194.75%881.03M

-234.49%-212.84M

119.41%621.04M

1,340.17%528.42M

44.29%-55.59M

Income tax

-24.93%203.12M

26.83%-65.04M

-14.44%157.4M

-40.86%117.86M

70.18%-7.1M

109.86%270.58M

-243.07%-88.89M

192.22%183.97M

595.70%199.31M

4.00%-23.81M

Net income

-37.06%384.19M

128.40%35.21M

-53.69%202.41M

-45.51%179.33M

-3.06%-32.76M

259.14%610.45M

-228.95%-123.96M

98.59%437.07M

561.85%329.11M

57.62%-31.78M

Net income continuous operations

-37.06%384.19M

128.40%35.21M

-53.69%202.41M

-45.51%179.33M

-3.06%-32.76M

259.14%610.45M

-228.95%-123.96M

98.59%437.07M

561.86%329.11M

57.62%-31.78M

Noncontrolling interests

Net income attributable to the company

-37.06%384.19M

128.40%35.21M

-53.69%202.41M

-45.51%179.33M

-3.06%-32.76M

259.14%610.45M

-228.95%-123.96M

98.59%437.07M

561.85%329.11M

57.62%-31.78M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-37.06%384.19M

128.40%35.21M

-53.69%202.41M

-45.51%179.33M

-3.06%-32.76M

259.14%610.45M

-228.95%-123.96M

98.59%437.07M

561.85%329.11M

57.62%-31.78M

Gross dividend payment

Basic earnings per share

-36.36%101.31

128.89%9.34

-53.16%53.39

-45.03%47.17

-3.74%-8.59

259.26%159.19

-228.97%-32.33

98.65%113.99

561.84%85.81

57.64%-8.28

Diluted earnings per share

-36.36%101.31

128.77%9.3029

-53.20%53.3441

-45.03%47.17

-3.74%-8.59

259.26%159.19

-228.97%-32.33

98.64%113.9799

561.84%85.81

57.64%-8.28

Dividend per share

-37.50%25

166.67%40

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	4.32%14.25B	20.89%3.44B	-7.64%4.22B	-6.14%3.65B	24.60%2.95B	21.73%13.66B	-9.93%2.84B	41.26%4.56B	48.56%3.89B	6.70%2.37B
Cost of revenue	4.99%9.85B	14.73%2.39B	-6.10%2.86B	-4.19%2.47B	27.11%2.13B	21.56%9.38B	-3.14%2.08B	44.34%3.05B	37.60%2.58B	5.77%1.68B
Gross profit	2.85%4.4B	37.75%1.05B	-10.73%1.36B	-9.96%1.18B	18.49%818.17M	22.10%4.28B	-24.43%761.04M	35.47%1.52B	76.19%1.31B	9.02%690.5M
Operating expense	12.00%3.83B	10.94%1.08B	10.64%995.52M	13.05%881.33M	13.88%875.24M	6.98%3.42B	16.28%974.49M	8.53%899.82M	-0.48%779.59M	2.64%768.57M
Operating profit	-33.76%566.73M	84.67%-32.73M	-41.81%359.73M	-43.88%296.8M	26.90%-57.07M	181.08%855.56M	-226.25%-213.45M	112.09%618.26M	1,398.19%528.82M	32.38%-78.07M
Net non-operating interest income (expenses)	4.96%-8.66M	-21.62%-2.7M	13.69%-2.5M	20.83%-1.88M	2.47%-1.58M	19.64%-9.11M	17.83%-2.22M	14.86%-2.9M	17.38%-2.37M	31.33%-1.62M
Non-operating interest expense	-4.96%8.66M	21.62%2.7M	-13.69%2.5M	-20.83%1.88M	-2.47%1.58M	-19.64%9.11M	-17.83%2.22M	-14.86%2.9M	-17.38%2.37M	-31.33%1.62M
Net investment income	4.76%13.2M	0	0	0	4.76%13.2M	4.51%12.6M	0	0	0	4.51%12.6M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	16.27%-6.13M	5.79%-1.73M	27.38%-1.33M	19.29%-1.48M	12.62%-1.6M	41.52%-7.32M	49.66%-1.83M	61.85%-1.83M	10.73%-1.83M	10.07%-1.83M
Less:Impairment of capital assets	-16.27%6.13M	-17.09%1.52M	-22.84%1.41M	-12.51%1.6M	-12.62%1.6M	-10.26%7.32M	-10.11%1.83M	-10.12%1.83M	-10.73%1.83M	-10.07%1.83M
Less:Other special charges	----	----	---83K	----	----	----	----	----	----	----
Other non-operating income (expenses)	-24.35%22.17M	57.36%7.32M	-47.99%3.91M	-1.55%3.75M	-46.04%7.2M	433.53%29.31M	203.96%4.65M	788.73%7.51M	25.05%3.81M	66.41%13.33M
Income before tax	-33.34%587.31M	85.98%-29.84M	-42.06%359.81M	-43.76%297.19M	28.31%-39.85M	194.75%881.03M	-234.49%-212.84M	119.41%621.04M	1,340.17%528.42M	44.29%-55.59M
Income tax	-24.93%203.12M	26.83%-65.04M	-14.44%157.4M	-40.86%117.86M	70.18%-7.1M	109.86%270.58M	-243.07%-88.89M	192.22%183.97M	595.70%199.31M	4.00%-23.81M
Net income	-37.06%384.19M	128.40%35.21M	-53.69%202.41M	-45.51%179.33M	-3.06%-32.76M	259.14%610.45M	-228.95%-123.96M	98.59%437.07M	561.85%329.11M	57.62%-31.78M
Net income continuous operations	-37.06%384.19M	128.40%35.21M	-53.69%202.41M	-45.51%179.33M	-3.06%-32.76M	259.14%610.45M	-228.95%-123.96M	98.59%437.07M	561.86%329.11M	57.62%-31.78M
Noncontrolling interests
Net income attributable to the company	-37.06%384.19M	128.40%35.21M	-53.69%202.41M	-45.51%179.33M	-3.06%-32.76M	259.14%610.45M	-228.95%-123.96M	98.59%437.07M	561.85%329.11M	57.62%-31.78M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-37.06%384.19M	128.40%35.21M	-53.69%202.41M	-45.51%179.33M	-3.06%-32.76M	259.14%610.45M	-228.95%-123.96M	98.59%437.07M	561.85%329.11M	57.62%-31.78M
Gross dividend payment
Basic earnings per share	-36.36%101.31	128.89%9.34	-53.16%53.39	-45.03%47.17	-3.74%-8.59	259.26%159.19	-228.97%-32.33	98.65%113.99	561.84%85.81	57.64%-8.28
Diluted earnings per share	-36.36%101.31	128.77%9.3029	-53.20%53.3441	-45.03%47.17	-3.74%-8.59	259.26%159.19	-228.97%-32.33	98.64%113.9799	561.84%85.81	57.64%-8.28
Dividend per share	-37.50%25	-37.50%25	0	0	0	166.67%40	166.67%40	0	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.